Verve Therapeutics, Inc.

Verve Therapeutics, Inc.verified

VERV

Price:

$4.705

Market Cap:

$398.16M

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and ...[Read more]

Industry

Biotechnology

IPO Date

2021-06-17

Stock Exchange

NASDAQ

Ticker

VERV

The PE Ratio as of October 2024 (TTM) for Verve Therapeutics, Inc. (VERV) is -1.82

According to Verve Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.82. This represents a change of -57.58% compared to the average of -4.29 of the last 4 quarters.

Verve Therapeutics, Inc. (VERV) Historical PE Ratio (quarterly & annually)

How has VERV PE Ratio performed in the past?

The mean historical PE Ratio of Verve Therapeutics, Inc. over the last ten years is -28.18. The current -1.82 PE Ratio has changed 545.82% with respect to the historical average. Over the past ten years (40 quarters), VERV's PE Ratio was at its highest in in the June 2024 quarter at -2.11. The PE Ratio was at its lowest in in the March 2020 quarter at -41.55.

Quarterly (TTM)
Annual

Average

-28.18

Median

-15.08

Minimum

-80.92

Maximum

-4.47

Verve Therapeutics, Inc. (VERV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Verve Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -4.47

Minimum Annual Increase = -58.24%

Minimum Annual PE Ratio = -80.92

Quarterly (TTM)
Annual
YearPE RatioChange
2023-4.47-32.68%
2022-6.64-55.94%
2021-15.08-55.39%
2020-33.79-58.24%

Verve Therapeutics, Inc. (VERV) Average PE Ratio

How has VERV PE Ratio performed in the past?

The current PE Ratio of Verve Therapeutics, Inc. (VERV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-8.73

5-year avg

-28.18

10-year avg

-28.18

Verve Therapeutics, Inc. (VERV) PE Ratio vs. Peers

How is VERV’s PE Ratio compared to its peers?

Verve Therapeutics, Inc.’s PE Ratio is greater than Adaptive Biotechnologies Corporation (-3.68), greater than Beam Therapeutics Inc. (-13.50), less than Caribou Biosciences, Inc. (-1.41), greater than Sana Biotechnology, Inc. (-4.06), greater than Intellia Therapeutics, Inc. (-3.42), less than Editas Medicine, Inc. (-1.37), greater than CRISPR Therapeutics AG (-14.44), greater than Prime Medicine, Inc. (-2.11), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than aTyr Pharma, Inc. (-2.33), greater than Relay Therapeutics, Inc. (-2.65), less than Century Therapeutics, Inc. (-0.93), greater than Blueprint Medicines Corporation (-27.05),

Build a custom stock screener for Verve Therapeutics, Inc. (VERV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verve Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verve Therapeutics, Inc. (VERV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verve Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Verve Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Verve Therapeutics, Inc. (VERV)?

What is the highest PE Ratio for Verve Therapeutics, Inc. (VERV)?

What is the 3-year average PE Ratio for Verve Therapeutics, Inc. (VERV)?

What is the 5-year average PE Ratio for Verve Therapeutics, Inc. (VERV)?

How does the current PE Ratio for Verve Therapeutics, Inc. (VERV) compare to its historical average?